Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
134
-
Total 13F shares, excl. options
-
5.61M
-
Shares change
-
-18.8K
-
Total reported value, excl. options
-
$313M
-
Value change
-
+$11.9M
-
Put/Call ratio
-
1.17
-
Number of buys
-
78
-
Number of sells
-
-47
-
Price
-
$55.82
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q2 2016
163 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q2 2016.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 134 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.61M shares
of 22.3M outstanding shares and own 25.16% of the company stock.
Largest 10 shareholders include Consonance Capital Management LP (817K shares), BlackRock Fund Advisors (661K shares), VANGUARD GROUP INC (386K shares), Healthcare Value Capital, LLC (345K shares), STATE STREET CORP (291K shares), Allianz Asset Management AG (198K shares), Fiera Capital Corp (190K shares), BlackRock Institutional Trust Company, N.A. (189K shares), NOMURA HOLDINGS INC (181K shares), and Invesco Ltd. (157K shares).
This table shows the top 134 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.